DATE: April 4, 2018
TIME: 8:00 AM PDT, 11:00 AM EDT
A recent report by CPhI highlights the pharmaceutical industry drive to improve productivity by improving right first time quality and reducing overhead costs1. Another report indicates that 79% of FDA 483 warning letters issued in 2016 cited data integrity issues2. Many quality control test procedures are still very manual and prone to human error, leading to errors and omissions in data records. So, we have an industry spending a large percentage of its operating costs trying to ensure product quality and in many cases failing while what is really needed is to automate the quality control processes to make them more robust and repeatable, delivering better right first time quality whilst at the same time improving data integrity and reducing operating costs.
References:
Biotechnology
Molecular Biology
Cancer Research
Biochemistry
Microbiology
Laboratory Testing
Cell Biology
Immunology
Genetics
Drug Discovery
Cancer Therapeutics
Molecular Diagnostics
Bioinformatics
Antibodies
Quality Control/assurance
North America51%
Europe17%
Asia16%
Africa6%
South America5%
Oceania1%
Website Visitors46%
Email Promotions23%
WAVE Newsletter Promotion15%
Social Media Promotions14%
Website Banners2%
Student17%
Facility/Department Manager10%
Medical Laboratory Technician9%
QC/QA9%
Executive8%
Research Scientist7%
Scientist6%
Medical Doctor/Specialist6%
Educator/Faculty5%
Lab Management4%
Engineer2%
Consultant2%
Microbiologist2%
Biologist2%
Clinical Laboratory Scientist2%
Pharmacist2%
Veterinarian2%
Chemist2%
Marketing/Sales1%
Academic Institution12%
Biotech Company12%
Hospital10%
Clinical Laboratory8%
Research Institute7%
Pharmaceutical Company6%
Medical Center3%
Life Science Company3%
Consultant3%
Government3%
Ambulatory Care2%
Industrial Company2%
Medical Device Company2%
Non-Profit Organization2%
Other9%